# OnCo record paper-kim-managed-entry-agreements-korea-front-pharmacol-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-kim-managed-entry-agreements-korea-front-pharmacol-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-kim-managed-entry-agreements-korea-front-pharmacol-2023" ;
  schema:name "Introduction of managed entry agreements in Korea: problem, policy and politics"@en ;
  schema:description "From January 2014 to 2020 Korea paid for most of the cancer and rare-disease medicines it listed through confidential risk-sharing contracts, almost all of them simple financial deals rather than payment for results."@en ;
  schema:url <https://onco.cc/key-papers/paper-kim-managed-entry-agreements-korea-front-pharmacol-2023/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.3389/fphar.2023.999220>, <https://pubmed.ncbi.nlm.nih.gov/37124231/> ;
  schema:sameAs <https://doi.org/10.3389/fphar.2023.999220> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Kim H, Godman B, Kwon HY, Hong SH" ;
  onco:institutions <https://onco.cc/institutions/hira/>, <https://onco.cc/institutions/nhis-korea/> .